John Anthony Dibella II Sells 1,000 Shares of Simulations Plus (NASDAQ:SLP) Stock

Simulations Plus, Inc. (NASDAQ:SLP) CRO John Anthony Dibella II sold 1,000 shares of the company’s stock in a transaction on Monday, July 6th. The shares were sold at an average price of $18.36, for a total value of $18,360.00. Following the completion of the sale, the executive owned 86,140 shares of the company’s stock, valued at approximately $1,581,530.40. This trade represents a 1.15% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

John Anthony Dibella II also recently made the following trade(s):

• On Wednesday, April 15th, John Anthony Dibella II sold 1,000 shares of Simulations Plus stock. The stock was sold at an average price of $13.37, for a total transaction of $13,370.00.

Simulations Plus Stock Performance

Shares of NASDAQ SLP traded down $0.01 during trading on Wednesday, hitting $18.27. The company had a trading volume of 393,694 shares, compared to its average volume of 389,041. Simulations Plus, Inc. has a 52 week low of $11.09 and a 52 week high of $21.01. The business’s 50-day moving average is $16.32 and its 200 day moving average is $15.48. The company has a market cap of $369.05 million, a P/E ratio of -5.84 and a beta of 1.30.

Simulations Plus (NASDAQ:SLP) last announced its earnings results on Thursday, April 9th. The technology company reported $0.35 EPS for the quarter, topping the consensus estimate of $0.27 by $0.08. Simulations Plus had a negative net margin of 77.96% and a positive return on equity of 16.21%. The company had revenue of $24.29 million during the quarter, compared to analysts’ expectations of $21.66 million. On average, research analysts expect that Simulations Plus, Inc. will post 0.8 EPS for the current year.

Institutional Trading of Simulations Plus

Several hedge funds have recently added to or reduced their stakes in the business. GAMMA Investing LLC grew its position in Simulations Plus by 26.0% in the 2nd quarter. GAMMA Investing LLC now owns 2,831 shares of the technology company’s stock worth $52,000 after purchasing an additional 585 shares during the last quarter. Bank of America Corp DE raised its position in shares of Simulations Plus by 13.2% during the first quarter. Bank of America Corp DE now owns 188,417 shares of the technology company’s stock valued at $2,227,000 after buying an additional 21,994 shares during the last quarter. Royal Bank of Canada lifted its stake in shares of Simulations Plus by 19.4% in the first quarter. Royal Bank of Canada now owns 30,414 shares of the technology company’s stock valued at $359,000 after buying an additional 4,947 shares during the period. Quantinno Capital Management LP lifted its stake in shares of Simulations Plus by 439.1% in the first quarter. Quantinno Capital Management LP now owns 112,259 shares of the technology company’s stock valued at $1,327,000 after buying an additional 91,434 shares during the period. Finally, First Light Asset Management LLC grew its position in Simulations Plus by 33.7% during the first quarter. First Light Asset Management LLC now owns 2,632,823 shares of the technology company’s stock worth $31,120,000 after buying an additional 663,906 shares in the last quarter. Institutional investors own 78.08% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on SLP shares. TD Cowen dropped their target price on Simulations Plus from $19.00 to $16.00 and set a “hold” rating on the stock in a research report on Friday, April 10th. Wall Street Zen cut Simulations Plus from a “buy” rating to a “hold” rating in a research note on Saturday, June 13th. Craig Hallum downgraded Simulations Plus from a “buy” rating to a “hold” rating and set a $18.50 price objective on the stock. in a report on Thursday, June 18th. William Blair lowered shares of Simulations Plus from an “outperform” rating to a “market perform” rating in a research report on Wednesday, June 17th. Finally, Weiss Ratings raised shares of Simulations Plus from a “sell (d-)” rating to a “sell (d)” rating in a research report on Friday, June 5th. One investment analyst has rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Simulations Plus presently has a consensus rating of “Hold” and an average target price of $19.88.

About Simulations Plus

Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.